Download PDF
J Reconstr Microsurg 2003; 19(7): 463-466
DOI: 10.1055/s-2003-44634
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Is Dextran Infusion as an Antithrombotic Agent Necessary in Microvascular Reconstruction of the Upper Aerodigestive Tract?

Tzong-Bor Sun1 , Sou-Hsin Chien1 , Jiunn-Tat Lee1 , Li-Fu Cheng1 , Lee-Ping Hsu2 , Peir-Rong Chen2
  • 1Division of Plastic Surgery, Department of Surgery, Buddhist Tzu Chi General Hospital and School of Medicine, Tzu Chi University, Hualien, Taiwan
  • 2Department of Otolaryngology, Buddhist Tzu Chi General Hospital and School of Medicine, Tzu Chi University, Hualien, Taiwan
Further Information

Publication History

Publication Date:
24 November 2003 (online)

    Permissions and Reprints

ABSTRACT

Patent microvascular anastomoses are mandatory for a successful free tissue transfer. Dextran 40 is widely used by reconstructive microsurgeons in conjunction with free tissue transfer, to prevent flap loss. Unfortunately, dextran-induced adverse reactions, such as anaphylactoid reactions, adult respiratory distress syndrome, cardiac overload, hemorrhage, and renal damage, remain the major risks in routine use of dextran 40. The authors retrospectively analyzed the patency rates of 55 microvascular tissue transfers of a single microsurgeon after tumor ablation of malignancies of the upper aerodigestive tract between August, 1997 and March, 2001. The patency rates of free flap reconstructions were 96 percent for the dextran-infusion group and 100 percent for the dextran-free group. There was no statistically significant difference between the patency rates of these two groups. The results showed that the routine use of dextran as an antithrombotic agent is not necessary in microvascular reconstruction. The disadvantages of dextran infusion can be effectively prevented.

KEYWORDS

Dextran - microvascular reconstruction - head and neck

REFERENCES

  • 1 Jones T R, Jones N F. Advance in reconstruction of the upper aerodigestive tract and cranial base with free tissue transfer.  Clin Plast Surg . 1992;  19 819-831
    PubMedGoogle Scholar
  • 2 Neligan P C, Mulholland S, Irish J. et al . Flap selection in cranial base reconstruction.  Plast Reconstr Surg . 1996;  98 1159-1196
    Google Scholar
  • 3 Sun T B, Lee J T, Chien S H. Surgical reconstruction for buccal cancer in eastern Taiwan.  Tzu Chi Med J . 1999;  11 131-138
    PubMedGoogle Scholar
  • 4 Talesnik A, Markowitz B, Calcaterra T. et al . Cost and outcome of osteocutaneous free-tissue transfer versus pedicled soft-tissue reconstruction for composite mandibular defects.  Plast Reconstr Surg . 1996;  97 1167-1178
    PubMedGoogle Scholar
  • 5 Stern J R, Keller A J, Wenig B L. Evaluation of reconstructive techniques of oropharyngeal defects.  Ann Plast Surg . 1989;  22 332-336
    PubMedGoogle Scholar
  • 6 O'Brien B M, Morrison W A, Gumley G J. Principles and techniques of microvascular surgery. In: McCarthy JG (ed.) Plastic Surgery, Philadelphia: W.B Saunders 1990: 412-473
    Google Scholar
  • 7 Glicksman A, Ferder M, Casale P. et al . 1457 years of microsurgery experience.  Plast Reconstr Surg . 1997;  100 355-363
    CrossrefPubMedGoogle Scholar
  • 8 Johnson P C, Baker J H. Thrombosis and antithrombotic therapy in microvascular surgery.  Clin Plast Surg . 1992;  19 799-807
    PubMedGoogle Scholar
  • 9 Wolfort S F, Angel M F, Knight K R. et al . The beneficial effect of dextran on anastomotic patency and flap survival in a strongly thrombogenic model.  J Reconstr Microsurg . 1992;  8 375-378
    PubMedGoogle Scholar
  • 10 Rothkopf D M, Chu B, Bern S. et al . The effect of dextran on microvascular thrombosis in an experimental rabbit model, Plast Reconstr Surg .  1993;  92 511-515
    PubMedGoogle Scholar
  • 11 Ljungstrom K G. The antithrombotic efficacy of dextran.  Acta Chir Scand Suppl . 1998;  543 26-30
    PubMedGoogle Scholar
  • 12 Rutherford R B, Jones D N, Bergentz S E. et al . The efficacy of dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass.  J Vasc Surg . 1984;  1 765-773
    PubMedGoogle Scholar
  • 13 Salemark L, Wieslander J B, Dougan P. et al . Studies of the antithrombotic effects of dextran 40 following microarterial trauma.  Br J Plast Surg . 1991;  44 15-22
    CrossrefPubMedGoogle Scholar
  • 14 Paull J. A prospective study of dextran-induced anaphylactoid reactions in 5745 patients.  Anesth Intens Care . 1987;  15 163-167
    PubMedGoogle Scholar
  • 15 Hein K D, Wechsler M E, Schwartzstein R M. et al . The adult respiratory distress syndrome after dextran infusion as an antithrombotic agent in free TRAM flap breast reconstruction.  Plast Reconstr Surg . 1999;  103 1706-1708
    CrossrefPubMedGoogle Scholar
  • 16 Taylor M A, DiBlasi S L, Bender R M. Adult respiratory distress syndrome complicating intravenous infusion of low-molecular weight dextran.  Cathet Cardiovasc Diagn . 1994;  32 249-253
    PubMedGoogle Scholar
  • 17 Brooks D, Okeefe P, Buncke H. Dextran induced acute renal failure after microvascular muscle transplantation: a case report. In: Wei FC, Chuang DCC, Chen HC, eds. Reconstructive Microsurgery Proceedings of the Inaugural Congress of the World Society for Reconstructive Microsurgery. Bologna Italy: Monduzzi Editore 2001: 469-471
    Google Scholar
  • 18 Bergqvist D. Dextran and hemostasis.  Acta Chir Scand . 1982;  148 633-640
    PubMedGoogle Scholar
  • 19 Kinlough-Rathbone R L, Packham M A, Mustard J F. Vessel injury, platelet adherence, and platelet survival.  Arteriosclerosis. . 1983;  3 529-546
    PubMedGoogle Scholar
  • 20 Ring J. Anaphylactoid reactions to plasma substitutes.  Int Anesthesiol Clin . 1985;  23 67-95
    PubMedGoogle Scholar
  • 21 Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes.  Lancet . 1977;  1 466-469
    PubMedGoogle Scholar
  • 22 Biesenbach G, Kaiser W, Zazgornik J. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage III or IV.  Renal Failure . 1997;  19 69-75
    PubMedGoogle Scholar
  • 23 Hardin C K, Kirk W C, Pederson W C. Osmotic complications of low-molecular-weight dextran therapy in free flap surgery.  Microsurgery . 1992;  13 36-38
    CrossrefPubMedGoogle Scholar
  • 24 Mulholland S, Boyd J B, McCabe S. et al . Recipient vessels in head and neck microsurgery: radiation effect and vessel access.  Plast Reconstr Surg . 1993;  92 628-632
    CrossrefPubMedGoogle Scholar
      >